BUD

Key Takeaways

At about $81, AB InBev trades near 13 times operating income, low enough that the price sits below what even a steady 5%-a-year decline in operating profit would warrant. Most valuation methods land at or above the price; only the pure asset-based reads call it expensive, which is typical for a brand-heavy business carried below its earning power. The first quarter of 2026 showed the model working. Revenue rose 5.8% organically to $15.3 billion on premiumization rather than volume, normalized E

Institutional ownership

538 institutional managers reported holding BUD in 13F filings for the quarter ended 2026-03-31. Together they hold about 5% of the company; the top 10 hold 3%. 89 opened new positions that quarter. Held by Dodge & Cox, Fisher Investments, Morgan Stanley, among others. On the short side, 6.5M shares were sold short as of the 2026-06-15 count, about 0.3% of shares outstanding (3.4 days of typical volume to cover).

Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.

Capital returns

It pays a dividend, and has paid one every year in our records (11 and counting). Cash returned over the past three years: $15.71B in dividends.

Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.

Compare BUD

ABEV vs BUDADM vs BUDBTI vs BUDBUD vs CCEPBUD vs DEOBUD vs HSY